Depression as chronobiological illness;A depresszió mint kronobiológiai betegség

Neuropsychopharmacologia Hungarica

Volumn 11, Issue 2, 2009, Pages 69-81

  Kálmán, János ^a   Kálmán, Sára ^a  

^a SZTE   (Hungary)

Author keywords

Agomelatine; Antidepressants; Chronobiology; Chronobiotics; Circadian rhytm; Clock genes; Depression; Melatonine

Indexed keywords

AGOMELATINE; MELATONIN;

AGE; ARTICLE; BEHAVIOR; CHRONOBIOLOGY; CIRCADIAN RHYTHM; DEPRESSION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG TARGETING; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; MENTAL DISEASE; MOLECULAR GENETICS; MOOD DISORDER; NEUROIMMUNOLOGY; PHOTOTHERAPY; PSYCHOBIOLOGY; RAPHE NUCLEUS; REGULATORY MECHANISM; SEASONAL VARIATION; SEX DIFFERENCE; SLEEP DEPRIVATION; SLEEP DISORDER; SOCIAL INTERACTION; STRESS; SUPRACHIASMATIC NUCLEUS; ULTRADIAN RHYTHM;

ACETAMIDES; AFFECT; BIOLOGICAL CLOCKS; CHRONOTHERAPY; CIRCADIAN RHYTHM; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; HUMANS; HYPNOTICS AND SEDATIVES; MELATONIN; MOOD DISORDERS; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDERS; SUPRACHIASMATIC NUCLEUS;

EID: 68349111663     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Albrecht U (2006). Orchestration of gene expression and physiology by the circadian clock. J Physiol Paris 100(5-6):243-51.
2. Asher G, Schibler U (2006). A CLOCK-less clock. Trends Cell Biol 16(11):547-9.
3. Audinot V, Mailliet F, Lahaye-Brasseur C, Bonnaud A, Le Gall A, Amossé C, Dromaint S, Rodriguez M, Nagel N, Galizzi JP, Malpaux B, Guillaumet G, Lesieur D, Lefoulon F, Renard P, Delagrange P, Boutin JA (2003). New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol 367(6):553-61.
4. Bánki MC (2006). Agomelatine: the first "melatoninergic" antidepressant. Neuropsychopharmacol Hung 8(3):105-12.
5. Benedetti F, Barbini B, Colombo C, Smeraldi E (2007). Chronotherapeutics in a psychiatric ward. Sleep Med Rev 11(6):509-22.
6. Berk M, Dodd S, Hallam K (2008). Small shifts in diurnal rhytms are associated with an increase in suicide: the effect of daylight saving. Sleep Biol. Rhythms (6) 22-25.
7. Bliwise DL (1993). Sleep in normal aging and dementia. Sleep 16:40-81.
8. Bódizs R (2006). Alvásszabályozás és hipnotikumok: A benzodiazepin-receptor agonisták hatásai. Neuropsychophamrcol Hung 8(3) 113-125.
9. Borbély AA, Wirz-Justice A (1982). Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1(3):205-10.
10. Buysse DJ, Frank E, Lowe KK, Cherry CR, Kupfer DJ (1997). Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry 15; 41(4):406-18.
11. Coogan AN, Wyse CA (2008). Neuroimmunology of the circadian clock. Brain Res 26;1232:104-12.
12. Daimon K, Yamada N, Tsujimoto T, Takahashi S (1992). Circadian rhythm abnormalities of deep body temperature in depressive disorders. J Affect Disord 26(3):191-8.
13. Dallman MF, Pecoraro N, Akana SF, la Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S (2003). Chronic stress and obesity: A new view of "comfort food" Proc Natl Acad Sci U S A 100(20): 11696-11701.
14. Desan PH, Oren DA, Malison R, Price LH, Rosenbaum J, Smoller J, Charney DS, Gelernter J (2000). Genetic polymorphism at the CLOCK gene locus and major depression. Am J Med Genet 12; 96 (3):418-21.
15. Dodig-Curkovic K, Kurbel S, Matic VC (2009). Can incidence of depression in women be linked to estrogen dependent secretion of various hormone binding proteins? Med Hypotheses 72(2):211-2.
16. Doi M, Hirayama J, Sassone-Corsi P (2006). Circadian regulator CLOCK is a histone acetyltransferase. Cell 125(3):497-508.
17. Dolberg OT, Hirschmann S, Grunhaus L (1998). Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 155(8):1119-21.
18. Estivil E, Bove A Garcia-Borreguero D (2003). Consensus on drug treatment definition and diagnosis for insomnia. Clin Drug Invest 23: 351-385.
19. Falcón E, McClung CA (2009). A role for the circadian genes in drug addiction. Neuropharmacology 56 Suppl 1:91-6.
20. Ford DE, Cooper-Patrick L (2001). Sleep disturbances and mood disorders: an epidemiologic perspective. Depress Anxiety 14(1):3-6.
21. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA (2008). Meta-Analysis of Short Sleep Duration and Obesity in Children and Adults. Sleep 31(5): 619-626.
22. Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM, Grochocinski V, Houck P, Scott J, Thompson W, Monk T (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 62(9): 996-1004.
23. Grimaldi B, Nakahata Y, Kaluzova M, Masubuchi S, Sassone-Corsi P (2009). Chromatin remodeling, metabolism and circadian clocks: The interplay of CLOCK and SIRT1. Int J Biochem Cell Biol 41(1):81-6.
24. Hamet P, Tremblay J (2006). Genetics of the sleep-wake cycle and its disorders. Metabolism 55(10 Suppl 2):S7-12.
25. Hirayama J, Nakamura H, Ishikawa T, Kobayashi Y, Todo T (2003). Functional and structural analyses of cryptochrome: vertebrate CRY regions responsible for interaction with the CLOCK:BMAL1 heterodimer and its nuclear localization. J Biol Chem 37: 35620-35628.
26. Hofman MA, Swaab DF (2006). Living by the clock: the circadian pacemaker in older people. Ageing Res Rev 5(1):33-51.
27. Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppä T, Lichtermann D, Praschak-Rieder N, Neumeister A, Nilsson LG, Kasper S, Peltonen L, Adolfsson R, Schalling M, Partonen T (2003). Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28(4):734-9.
28. Kalsbeek A, Buijs RM, van Heerikhuize JJ, Arts M, van der Woude TP (1992). Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res 15;580(1-2):62-7.
29. Kennedy SH, Emsley R (2006). Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 16(2):93-100.
30. Korf HW, von Gall C (2006). Mice, melatonin and the circadian system. Mol Cell Endocrinol 252(1-2): 57-68.
31. Kriegsfeld LJ, Silver R (2006). The regulation of neuroendocrine function: Timing is everything. Horm Behav 49(5):557-74.
32. Lamont EW, James FO, Boivin DB, Cermakian N (2007). From circadian clock gene expression to pathologies. Sleep Med 8(6):547-56.
33. Lemoine P, Guilleminault C, Alvarez E (2007). Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatry 68(11):1723-32.
34. Leproult R, Van Onderbergen A, L'hermite-Balériaux M, Van Cauter E, Copinschi G (2005). Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf) 63(3):298-304.
35. Lewy AJ, Sack RL, Latham J (1991). A phase response curve for melatonin administration in humans. Sleep Res 20:461.
36. Lincoln GA (2002). Neuroendocrine regulation of seasonal gonadotrophin and prolactin rhythms: lessons from the Soay ram model. Reprod Suppl 59:131-47.
37. Liu HC, Hu CJ, Tang YC, Chang JG (2008). A pilot study for circadian gene disturbance in dementia patients. Neurosci Lett 435(3):229-33.
38. Loo CK, Mitchell PB, Croker VM, Malhi GS, Wen W, Gandevia SC, Sachdev PS (2003). Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychol Med 33(1):33-40.
39. Manev H, Uz T (2006). Clock genes: influencing and being influenced by psychoactive drugs. Trends Pharmacol Sci 27(4):186-9.
40. McClung CA (2007). Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 114(2): 222-32.
41. Mendlewicz J, Linkowski P, Kerkhofs M, Desmedt D, Golstein J, Copinschi G, Van Cauter E (1985). Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab 60(3):505-12.
42. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D (2003). The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306(3):954-64.
43. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients withcancer. J Clin Oncol 20(6):971-982.
44. Monteleone P, Maj M (2008). The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol 18(10):701-11.
45. Motivala SJ, Levin MJ, Oxman MN, Irwin MR (2006). Impairments in health functioning and sleep quality in older adults with a history of depression. J Am Geriatr Soc 54(8): 1184-1191.
46. Nievergelt CM, Kripke DF, Barrett TB, Burg E, Remick RA, Sadovnick AD, McElroy SL, Keck PE Jr, Schork NJ, Kelsoe JR (2006). Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 141B(3):234-41.
47. Oklejewicz M, Destici E, Tamanini F, Hut RA, Janssens R, van der Horst GT (2008). Phase resetting of the mammalian circadian clock by DNA damage. Curr Biol 18(4): 286-91.
48. Papp M, Gruca P, Boyer PA, Mocaër E (2003). Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28(4):694-703.
49. Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, Aron L, Rietschel M, Wellek S, Soronen P, Paunio T, Koch A, Chen P, Lathrop M, Adolfsson R, Persson ML, Kasper S, Schalling M, Peltonen L, Schumann G (2007). Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 39(3):229-38.
50. Pirraglia PA, Gupta S (2007). The interaction of depression and diabetes: a review. Curr Diabetes Rev 3(4): 249-51.
51. Purebl G, Székely A, Bagi M, Kopp M (2008). Experience with the Hungarian program of the European Association Against Depression. Psychiatr Hung 23(4):252-4.
52. Quera Salva MA, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C (2007). Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol 10(5):691-6.
53. Racagni G, Riva MA, Popoli M (2007). The interaction between the internal clock and antidepressant efficacy. Int Clin Psychopharmacol 22 (Suppl 2):S9-S14.
54. Rudolph U, Mohler H (2006). GABA-based therapeutic approaches: GABA-A receptor subtype functions. Curr Opin Pharmacol 6:18-23.
55. Sephton S, Spiegel D (2003). Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun. 17 (5):321-8.
56. Shinohara A, Koyanagi S, Hamdan AM, Matsunaga N, Aramaki H, Ohdo S (2008). Dosing schedule-dependent change in the disruptive effects of interferon-alpha on the circadian clock function. Life Sci 83(15-16):574-80.
57. Srinivasan V, Smits M, Spence W, Lowe AD, Kayumov L, Pandi-Perumal SR, Parry B, Cardinali DP (2006). Melatonin in mood disorders. World J Biol Psychiatry 7(3):138-51.
58. Sterpenich V, Albouy V, Boly M, Vandewalle G, Darsaud A, Balteau E, Dang-Vu TT, Desseilles M, D'Argembeau A, Gais S, Rauchs G, Schabus M, Degueldre C, Luxen A, Collette F, Maquet P (2007). Sleep-Related Hippocampo-Cortical Interplay during Emotional Memory Recollection. PLoS Biol 5(11): e282.
59. Swaab DF, Bao AM, Lucassen PJ (2005). The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4(2):141-94.
60. Turek FW (2007). From circadian rhythms to clock genes in depression. Int Clin Psychopharmacol 22 (Suppl 2):S1-8.
61. Tuunainen A, Kripke DF, Endo T (2004). Light therapy for non-seasonal depression. Cochrane Database Syst Rev (2):CD004050.
62. Van Cauter E, Copinschi G (2000). Interrelationships between growth hormone and sleep. Growth Horm IGF Res 10 (Suppl) B:S57-62.
63. Wirz-Justice A (2006). Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 21 (Suppl 1):S11-5.
64. Yin L, Wang J, Klein PS, Lazar MA (2006). Nuclear receptor Reverb-alpha is a critical lithium-sensitive component of the circadian clock. Science 311:1002-1005.
65. Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman, MA, Swaab DF (2001). Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry 58(7):655-62.